Hot Stocks

The stock market changes from minute to minute, and what’s hot today may not be hot tomorrow. Our expert analysts spot hot stocks that are heating up before the crowd swoops in to bid prices higher, and our journalists sift through the noise to shine a light on trending investments -- in spaces ranging from quantum computing to marijuana stocks -- to determine whether they’re actually worth your time.

Citigroup (C) a Buy on Robust Earnings Visibility

By Portfolio Grader
Citigroup Inc (NYSE:C) is classified as a component of the 343 company Banks GICS industry group, which is a segment of the 766 company GICS Financials sector. C has a market value of $195.8 billion which is in the top decile in its industry group. The ranking for C by Portfolio Grader places it 103 among the 343 companies in this industry group, putting it in the second quartile; in the top half of the sector with a ranking of 231 among the 766 companies in the sector, and number 1,422 in the nearly 5,000 company Portfolio Grader universe.

Robust Earnings Momentum Make HSBC Holdings plc Sponsored ADR (HSBC) a Buy

By Portfolio Grader
The current recommendation of Buy for HSBC Holdings plc Sponsored ADR (NYSE:HSBC) is computed using the approach of Louis Navellier for investing and his Portfolio Grader stock evaluator. The current Portfolio Grader recommendation on the shares has been in place for 2 months.

Intel Corporation Stock Is Massively Overbought, But Should You Sell Now?

By Bret Kenwell, InvestorPlace Contributor
Intel stock has been soaring post-earnings. INTC stock price is now overbought, but investors should buy on a pullback.

Wells Fargo & Co (WFC) a Sell on Slumping Earnings Growth

By Portfolio Grader
Currently, Wells Fargo & Co (NYSE:WFC) has a Sell using Louis Navellier's investing methods and his Portfolio Grader stock evaluator. The current Portfolio Grader recommendation on the shares has been in place for the last month.

Eroding Earnings Visibility Drops Bank of America (BAC) to Hold

By Portfolio Grader
Bank of America Corp (NYSE:BAC) is ranked as a Hold using the Portfolio Grader stock evaluator of Louis Navellier, which incorporates his investing methods. The shares have been downgraded from a Buy to a Hold in the last week.

Earnings Growth Keep JPMorgan Chase & Co (JPM) a Buy

By Portfolio Grader
JPMorgan Chase & Co (NYSE:JPM) is classified as a member of the 343 company Banks GICS industry group, which is part of the 766 company GICS Financials sector. JPM has a market value of $351.9 billion which is in the top decile in its industry group. Portfolio Grader's current ranking for JPM puts it 108 among the 343 companies in this industry group, putting it in the second quartile; in the top half of the sector with a ranking of 241 among the 766 companies in the sector, and number 1,517 in the nearly 5,000 company Portfolio Grader universe.

Industry Group Rank Limit Berkshire Hathaway Energy (BRK.B) Rating

By Portfolio Grader
Berkshire Hathaway Energy Co (NYSE:BRK.B) is ranked as a Hold using Louis Navellier's Portfolio Grader stock evaluator, which incorporates his investing methodology. BRK.B has maintained this ranking for 4 months.

Weak Earnings Growth Drops Banco Santander Brasil (BSBR) to Hold

By Portfolio Grader
Banco Santander Brasil SA (NYSE:BSBR) is a component of the 343 company Banks GICS industry group, which is part of the 766 company GICS Financials sector. BSBR has a market value of $34,054.7 billion which is in the top decile in its industry group. Portfolio Grader's current ranking for BSBR puts it 150 among the 343 companies in this industry group, putting it in the second quartile; in the top half of the sector with a ranking of 333 among the 766 companies in the sector, and number 2,098 in the nearly 5,000 company Portfolio Grader universe.

Tesla Inc Stock Is a Dip Buy for Sure, Here’s Why

By Luke Lango, InvestorPlace Senior Investment Analyst
TSLA stock is trading under $300 for the first time in months following ugly Q3 earnings; this drubbing looks like an opportunity.

Elon Musk’s Musings Aren’t a Reason to Sell Your Nvidia Corporation Stock

By James Brumley, InvestorPlace Feature Writer
After Tesla's CEO rambled on about Nvidia's future in his cars, NVDA stock got a scare. Ignore Elon Musk's stream of consciousness.

Can The Cloud Push Microsoft Corporation Stock Past Decade-High Valuation?

By Luke Lango, InvestorPlace Senior Investment Analyst
Microsoft's growth rates continue to accelerate, fueled by its cloud business. MSFT stock is richly valued but looks good below $90.

Alnylam Pharmaceuticals (ALNY) a Buy on Healthy Quant Score

By Portfolio Grader
Currently, Alnylam Pharmaceuticals Inc (NASDAQ:ALNY) has a Buy using the Portfolio Grader stock evaluator, which incorporates Louis Navellier's investing methodology. The current Portfolio Grader recommendation on the shares has been in place for the last month.

Earnings Growth Make BioMarin Pharmaceuticals (BMRN) a Sell

By Portfolio Grader
Portfolio Grader currently ranks BioMarin Pharmaceuticals (NASDAQ:BMRN) a Sell. Using Louis Navellier's investing methodology, this analytical tool researches stocks by means of fundamental and quantitative analytical tools. BMRN has maintained this ranking for 4 months.

Strong Quant Score Make Immuron Limited Sponsored ADR (IMRN) a Buy

By Portfolio Grader
The current recommendation of Buy for Immuron Limited Sponsored ADR (NULL:IMRN) is the result of using the methodology of Louis Navellier for investing and his Portfolio Grader stock evaluator. The current Portfolio Grader recommendation on the shares has been in place for 4 months.

Vapid Earnings Visibility Restrict Incyte (INCY) Rating

By Portfolio Grader
Incyte Corp (NASDAQ:INCY) is a $22.2 billion in market value member of the Biotechnology GICS industry group where Portfolio Grader's current ranking for INCY puts it 171 among the 349 companies in this industry group, placing it in the top half. INCY is ranked in the third quartile of the sector with a ranking of 402 among the 785 companies in the sector and number 2,601 in the 5000 company Portfolio Grader company universe.

Weak Sales Growth Drop Alexion Pharmaceuticals (ALXN) to Sell

By Portfolio Grader
Alexion Pharmaceuticals Inc (NASDAQ:ALXN) is a $26.3 billion in market value component of the Biotechnology GICS industry group where The current Portfolio Grader ranking for ALXN puts it 207 among the 349 companies in this industry group, which is a below-average position. ALXN is ranked in the third quartile of the sector with a ranking of 480 among the 785 companies in the sector and number 3,109 in the 5000 company Portfolio Grader company universe.

Vertex Pharmaceuticals (VRTX) a Buy on Strong Sales Growth

By Portfolio Grader
As one of the 785 companies in the GICS Health Care sector Vertex Pharmaceuticals Inc (NASDAQ:VRTX) is a member of the 349 company Biotechnology GICS industry group within this sector. VRTX's market value is $37.9 billion which falls in the top decile in its industry group. Portfolio Grader's current ranking for VRTX puts it 81 among the 349 companies in this industry group, putting in the top quartile; in the top half of the sector with a ranking of 222 among the 785 companies in the sector, and number 1,463 in the nearly 5,000 company Portfolio Grader universe.

Adverse Earnings Growth Keep MLP & Strategic Equity Fund (MTP) a Sell

By Portfolio Grader
As one of the 785 companies in the GICS Health Care sector MLP & Strategic Equity Fund (NASDAQ:MTP) is a member of the 349 company Biotechnology GICS industry group within this sector. MTP has a market value of $42.7 billion which is in the top decile in its industry group. The stock's current Portfolio Grader ranking places it 272 among the 349 companies in this industry group, a position that is well below-average; squarely in the bottom quartile of the sector with a ranking of 622 among the 785 companies in the sector, and number 3,828 in the nearly 5,000 company Portfolio Grader universe.

Poor Quant Score Limit Regeneron Pharmaceuticals (REGN) Rating

By Portfolio Grader
Currently, Regeneron Pharmaceuticals Inc (NASDAQ:REGN) has a Hold using the methodology for investing of Louis Navellier and his Portfolio Grader stock evaluator. REGN has maintained this ranking for 5 months.
Load More Articles